https://nl.marketscreener.com/koers/aandeel/IMMUNIC-INC-57237730/nieuws/Immunic-Inc-Presenteert-gegevens-van-fase-1b-klinische-studie-van-IMU-856-in-coeliakie-op-de-Unite-45067052/?utm_source=telegram&utm_medium=social&utm_campaign=share